Emcure Pharmaceuticals Ltd (EMCURE) — Net Asset Momentum
Emcure Pharmaceuticals Ltd (EMCURE) recorded a net asset momentum of 7.2% as of March 2026, with net assets of Rs49.77 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See operational self-sufficiency of Emcure Pharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Emcure Pharmaceuticals Ltd Net Asset Momentum (2022–2026)
This chart tracks Emcure Pharmaceuticals Ltd's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +7.2%, with net assets of Rs49.77 Billion INR as of March 2026. Read EMCURE liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for Emcure Pharmaceuticals Ltd (2022–2026)
The table below shows the complete annual net asset history for Emcure Pharmaceuticals Ltd from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Emcure Pharmaceuticals Ltd.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs49.77 Billion | Rs96.12 Billion | Rs46.36 Billion | ▲ +7.2% |
| 2025 | Rs46.42 Billion | Rs82.33 Billion | Rs35.91 Billion | ▲ +48.7% |
| 2024 | Rs31.22 Billion | Rs78.06 Billion | Rs46.84 Billion | ▲ +17.8% |
| 2023 | Rs26.50 Billion | Rs66.73 Billion | Rs40.23 Billion | ▲ +25.3% |
| 2022 | Rs21.14 Billion | Rs60.63 Billion | Rs39.49 Billion | — |